New Chief Restructuring Officer and Chief Transformation Officer appointed
News Provided by GlobeNewswire2020-11-23
15 Views
Schlieren/Switzerland, 24 November 2020
The news release can be downloaded from the following link:
Attachment
© 2020 GlobeNewswire, Inc. All Rights Reserved.
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis
